Is The Market Turning The Page?
CoreWeave’s debt and equity price action is framed as a wake-up call for investors amid a broader market discussion.
CoreWeave’s debt and equity price action is framed as a wake-up call for investors amid a broader market discussion.
Lots of financials like insurance brokers, banks, retail brokerages getting smoked on Muse / agentic concerns / cash sweeps / wealth mgmt? $SCHW, $LPLA, $RJF all getting crushed along with all of insurance Looks like sell first, think later is back https://t.co/pvWN2aytg3
$MDT $MMED exchange offer an interesting special sit… Own shares of MDT and swap for MMED at 7% discount Odd lot provision for 99 shares held too High enough share price to be worthwhile ($90+ MDT price works out to $600+ profit in a few weeks time)
$LDOS looks interesting to me. They provide a variety of government services including healthcare, intelligence, defence and homeland security stuff. Currently overearning due to a VA healthcare contract that will be renegotiated lower going into 2027. The market has sold them
Know fins are selling off today, but the $JEF underperformance since Radiant World feels like perception <> reality. We literally just saw this movie with First Brands: scary headline, fears of a much bigger balance-sheet problem, then the actual exposure comes into focus. Fool me once…
$SRAD is explicitly mentioned in $META Muse source code & technical documentation - although functionality does not appear to have been turned on yet I believe Meta will expand their relationship with Sportradar https://t.co/OS10T9268i https://t.co/MzTsyf3WV0
I've been flat out wrong on $NEN and no longer own it, so it probably works now. ICYMI, the Brown family filed a 13D as a group in June for the first time since Harold passed. I found this sentence interesting. From what I can tell, this language wasn't in any historical family ownership filings.
@310Value reminder that $APG pfd A stock, by which the holders get paid hedge fund-like incentive comp based on year end share price, will be converted at year end. Management/board are well incentivized to do everything they can to juice the stock price into year end.
Dream Finders Homes’ controlling owner borrowed against DFH stock before the homebuilder agreed to finance an acquisition with costly…
Park Aerospace’s 11% Q2’27 sell-off overlooks sole-source PAC-3 rocket-motor materials and A320neo engine composites, with missile capacity…
UniQure's Huntington's gene therapy faces an FDA accelerated-approval decision around November 1 after three-year data met both agency…
Marvell is positioning networking, optical connectivity and server-management chips as AI data centers link GPUs, custom accelerators and…
AeroVironment's $465M LOCUST laser award and earnings beat support its 2027 growth outlook despite government budget uncertainty.
Constellation Brands trades near $127 at roughly 11x next-twelve-month EV/EBIT, with recent business results offsetting concerns over…
Transocean’s Valaris merger clears regulators, creating a 68-rig offshore driller controlling four in 10 global drillships.
October 2026 market commentary covers SOLS’s cancelled merger, a hypothetical Starbucks-Chipotle deal, Russell 2000 weakness and AI…
CoreWeave faces fresh skepticism as another AI trade selloff collides with bullish defenses of the company.
Ari Emanuel discusses AI’s impact on Hollywood, live events, social networks and the future of advertising.
BLND · long Blend Labs (BLND) is presented as a long investment idea, with prior VIC writeups cited for business background.
Shenandoah Telecommunications’ Glo Fiber buildout ends this year, and private infrastructure investors’ repeated fiber deals frame a…
RTX’s $289 billion backlog, including $119 billion in defense, supports growth from defense contracts and commercial aerospace aftermarket…
Morgan Stanley Direct Lending trades at a 32% NAV discount as non-accruals reach 2.9%, NII and NAV decline, and dividend coverage falls to…
Applied Materials leads wafer-fab deposition and ranks third in etch, positioning it for tougher 3D chip manufacturing as investors weigh a…
First Tracks Biotherapeutics’ ANB033 posted stronger Phase 1b celiac efficacy than Teva’s IL-15 inhibitor, with $168 million funding…
Howmet Aerospace is framed as a beneficiary of turbine and aircraft-engine demand, while J.B.
Lennar cut build times to 116 days and adopted an asset-light land model, while gross margin fell to 15.8% from 27.5% as land costs rose.
Lennar grew from a Miami builder into one of America’s two largest homebuilders, controlling land largely through options and land banks…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.